Warburg Pincus Completes $241.5M Partial Exit From China Biologic

This Data Is Locked!

This area is available only to Subscribers.

Private equity firm Warburg Pincus LLC has completed a partial exit from portfolio company, NASDAQ-listed China Biologic Products, receiving US$241.5 million in total proceeds, according... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?